Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	53.39	72.9	76.68	108.91	77.83	63.56
Cash & Short-Term Investments	53.39	72.9	76.68	108.91	77.83	63.56
Cash Growth	-32.12%	-4.92%	-29.60%	39.93%	22.45%	586.84%
Other Current Assets	0.98	1.6	1.59	2.03	1.92	1.37
Total Current Assets	54.37	74.51	78.26	110.94	79.75	64.93
Net Property, Plant & Equipment	1.46	2.07	2.87	2.95	0.64	1.03
Other Long-Term Assets	0.33	0.32	0.31	0.3	-	0.44
Total Assets	56.15	76.9	81.45	114.19	80.39	66.4
Accounts Payable	6.22	7.57	7.95	10.13	5.54	4.34
Current Portion of Leases	0.61	0.58	0.54	0.5	0.31	0.43
Unearned Revenue	-	-	-	-	1	-
Total Current Liabilities	6.83	8.15	8.49	10.63	6.84	4.77
Long-Term Leases	0.53	0.99	1.57	2.08	0	0.31
Other Long-Term Liabilities	35	35	35	35	-	-
Total Long-Term Liabilities	35.53	35.99	36.57	37.08	0	0.31
Total Liabilities	42.37	44.14	45.07	47.71	6.84	5.08
Common Stock	0.03	0.03	0.03	0.03	0.02	0.02
Additional Paid-in Capital	417.53	408.55	373.93	355.22	329.27	292.28
Retained Earnings	-403.77	-375.83	-337.58	-288.77	-255.75	-230.97
Shareholders' Equity	13.78	32.76	36.38	66.48	73.55	61.32
Total Liabilities & Equity	56.15	76.9	81.45	114.19	80.39	66.4
Total Debt	1.14	1.57	2.11	2.58	0.31	0.74
Net Cash (Debt)	52.25	71.33	74.56	106.33	77.52	62.82
Net Cash Growth	-26.75%	-4.34%	-29.87%	37.16%	23.39%	702.73%
Net Cash Per Share	1.68	2.37	2.80	4.40	3.77	5.18
Book Value	13.78	32.76	36.38	66.48	73.55	61.32
Book Value Per Share	0.44	1.09	1.37	2.75	3.58	5.05
Tangible Book Value	13.78	32.76	36.38	66.48	73.55	61.32
Tangible Book Value Per Share	0.44	1.09	1.37	2.75	3.58	5.05

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q